{"disease":{"id":"chemotherapy-induced-thrombocytopenia","name":"chemotherapy induced thrombocytopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05688306","title":"To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":3494,"lead_sponsor_name":"Liaoning Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT06809101","title":"Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries.","phase":"","overall_status":"RECRUITING","enrollment_count":265,"lead_sponsor_name":"Pomeranian Medical University Szczecin","has_results":false},{"nct_id":"NCT07408648","title":"A Clinical Study on the Efficacy and Safety of Hetrombopag in the Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":244,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03362177","title":"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03937154","title":"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":145,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT03976882","title":"Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT03471078","title":"Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Sobi, Inc.","has_results":true},{"nct_id":"NCT06769685","title":"TPO Combined With TPORA for Solid Tumors Effectiveness of cTit Above Degree II","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":100,"lead_sponsor_name":"Jinhua Central Hospital","has_results":false},{"nct_id":"NCT05969158","title":"Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in Lymphoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07243418","title":"Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT05554913","title":"Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT02052882","title":"Study of Romiplostim for Chemotherapy Induced Thrombocytopenia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT06440824","title":"A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human Thrombopoietin","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT05772546","title":"Avatrombopag vs. Placebo for CIT in GI Malignancies","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Hanny Al-Samkari, MD","has_results":false},{"nct_id":"NCT05236582","title":"Herombopag for Chemotherapy-induced Thrombocytopenia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07043894","title":"Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT05218226","title":"Avatrombopag for Chemotherapy-induced Thrombocytopenia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04600960","title":"Eltrombopag for Chemotherapy-induced Thrombocytopenia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05851027","title":"Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06099925","title":"The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic Malignancies","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":48,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT07492693","title":"Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Changhai Hospital","has_results":false},{"nct_id":"NCT07252375","title":"A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":35,"lead_sponsor_name":"Fujian Cancer Hospital","has_results":false},{"nct_id":"NCT06523088","title":"A Study of PN20 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Chongqing Peg-Bio Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT07048249","title":"Single Arm Romiplostim to Prevent CIT","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":26,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT03343847","title":"Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Lymphoma.","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05261646","title":"A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false}],"total":26},"guidelines":[],"source":"Drug Landscape verified database"}